Global Microgravity Biopharmaceuticals Market Growth (Status and Outlook) 2026-2032

July 2026 | 111 pages | ID: G0AC2DE8DF27EN
LP Information

Abstracts

The global Microgravity Biopharmaceuticals market size is predicted to grow from US$ 63.97 million in 2025 to US$ 129 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.

Microgravity biopharmaceuticals is an interdisciplinary field that utilizes the microgravity environment provided by space stations, sounding rockets, and other similar facilities to conduct research on key aspects of drug development and production. Its core lies in the fact that microgravity can significantly suppress gravity-driven convection and sedimentation effects, thereby creating homogenization conditions that cannot be simulated on Earth. This is primarily used for high-quality protein crystallization and the development of novel drug formulations and efficient production processes. This technology aims to overcome bottlenecks in terrestrial research and development and is one of the most commercially promising directions for space-based biomanufacturing.

The microgravity biopharmaceuticals market is at a critical juncture, transitioning from exploratory research to early-stage commercialization. Currently, the market is primarily driven by collaborations between government space agencies and large pharmaceutical companies, focusing on two high-value areas: high-quality protein crystallization and advanced disease model development. As commercial space companies offer more economical launch and platform services, the barriers to entry continue to decrease, attracting a number of biotech startups focused on specific therapeutic areas such as cancer and neurodegenerative diseases. However, the overall market size remains limited, with the vast majority of projects still in the research and validation phase. Future development heavily relies on comparative experiments to definitively demonstrate that microgravity environments can systematically produce commercially viable research results or products superior to those on Earth, ensuring continued industry investment.

This report presents a comprehensive overview, market shares, and growth opportunities of Microgravity Biopharmaceuticals market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Protein Crystal Growth
• Microbial Fermentation
• Advanced Disease Model Construction
• Others

Segmentation by Orbital Altitude:

• Low Earth Orbit (160?2000 km)
• Medium Earth Orbit (2,000?35,786 km)
• Geostationary Orbit (35,786 km)

Segmentation by Bioreactor Capacity:

• 1?10 L
• 10?100 L
• Over 100 L

Segmentation by Application:

• New Drug Discovery
• Preclinical Research and Translational Medicine
• Others

This report also splits the market by region:

• United States
• China%li%
• Europe
• Other regions
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• BioOrbit
• Eascra Biotech
• Exobiosphere
• Space LiinTech
• SpacePharma
• Varda Space Industries
• Voyager Technologies
• Sierra Space
• Space Phoenix Systems
• Rhodium Scientific
• Beijing Dawn Aerospace Bio-Tech
• CASC

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microgravity Biopharmaceuticals Market Size 2026-2032
  2.1.2 Microgravity Biopharmaceuticals Market Size CAGR by Region
2.2 Microgravity Biopharmaceuticals Segment by Type
  2.2.1 Protein Crystal Growth
  2.2.2 Microbial Fermentation
  2.2.3 Advanced Disease Model Construction
  2.2.4 Others
  2.2.5 Microgravity Biopharmaceuticals Market Size by Type
    2.2.5.1 Global Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
    2.2.5.2 Global Microgravity Biopharmaceuticals Market Size Growth Rate by Type (2026-2032)
2.3 Microgravity Biopharmaceuticals Segment by Orbital Altitude
  2.3.1 Low Earth Orbit (160?2000 km)
  2.3.2 Medium Earth Orbit (2,000?35,786 km)
  2.3.3 Geostationary Orbit (35,786 km)
  2.3.4 Microgravity Biopharmaceuticals Market Size by Orbital Altitude
    2.3.4.1 Global Microgravity Biopharmaceuticals Market Size Market Share by Orbital Altitude (2026-2032)
    2.3.4.2 Global Microgravity Biopharmaceuticals Market Size Growth Rate by Orbital Altitude (2026-2032)
2.4 Microgravity Biopharmaceuticals Segment by Bioreactor Capacity
  2.4.1 1?10 L
  2.4.2 10?100 L
  2.4.3 Over 100 L
  2.4.4 Microgravity Biopharmaceuticals Market Size by Bioreactor Capacity
    2.4.4.1 Global Microgravity Biopharmaceuticals Market Size Market Share by Bioreactor Capacity (2026-2032)
    2.4.4.2 Global Microgravity Biopharmaceuticals Market Size Growth Rate by Bioreactor Capacity (2026-2032)
2.5 Microgravity Biopharmaceuticals Segment by Application
  2.5.1 New Drug Discovery
  2.5.2 Preclinical Research and Translational Medicine
  2.5.3 Others
  2.5.4 Microgravity Biopharmaceuticals Market Size by Application (2026-2032)
    2.5.4.1 Global Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
    2.5.4.2 Global Microgravity Biopharmaceuticals Market Size Growth Rate by Application (2026-2032)

3 MICROGRAVITY BIOPHARMACEUTICALS KEY PLAYERS

3.1 Date of Key Players Enter into Microgravity Biopharmaceuticals
3.2 Key Players Microgravity Biopharmaceuticals Product Offered
3.3 Key Players Microgravity Biopharmaceuticals Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Microgravity Biopharmaceuticals Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 MICROGRAVITY BIOPHARMACEUTICALS BY REGIONS

4.1 Microgravity Biopharmaceuticals Market Size by Regions (2026-2032)
4.2 United States Microgravity Biopharmaceuticals Market Size Growth (2026-2032)
4.3 China Microgravity Biopharmaceuticals Market Size Growth (2026-2032)
4.4 Europe Microgravity Biopharmaceuticals Market Size Growth (2026-2032)
4.5 Rest of World Microgravity Biopharmaceuticals Market Size Growth (2026-2032)

5 UNITED STATES

5.1 United States Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
5.2 United States Microgravity Biopharmaceuticals Market Size by Application (2026-2032)

6 EUROPE

6.1 Europe Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
6.2 Europe Microgravity Biopharmaceuticals Market Size by Application (2026-2032)

7 CHINA

7.1 China Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
7.2 China Microgravity Biopharmaceuticals Market Size by Application (2026-2032)

8 REST OF WORLD

8.1 Rest of World Microgravity Biopharmaceuticals Market Size by Type (2026-2032)
8.2 Rest of World Microgravity Biopharmaceuticals Market Size by Application (2026-2032)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN MICROGRAVITY BIOPHARMACEUTICALS

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ??

11 KEY PLAYERS ANALYSIS

11.1 BioOrbit
  11.1.1 BioOrbit Company Details
  11.1.2 BioOrbit Microgravity Biopharmaceuticals Product Offered
  11.1.3 BioOrbit Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.1.4 BioOrbit Main Business Overview
  11.1.5 BioOrbit News
11.2 Eascra Biotech
  11.2.1 Eascra Biotech Company Details
  11.2.2 Eascra Biotech Microgravity Biopharmaceuticals Product Offered
  11.2.3 Eascra Biotech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.2.4 Eascra Biotech Main Business Overview
  11.2.5 Eascra Biotech News
11.3 Exobiosphere
  11.3.1 Exobiosphere Company Details
  11.3.2 Exobiosphere Microgravity Biopharmaceuticals Product Offered
  11.3.3 Exobiosphere Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.3.4 Exobiosphere Main Business Overview
  11.3.5 Exobiosphere News
11.4 Space LiinTech
  11.4.1 Space LiinTech Company Details
  11.4.2 Space LiinTech Microgravity Biopharmaceuticals Product Offered
  11.4.3 Space LiinTech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.4.4 Space LiinTech Main Business Overview
  11.4.5 Space LiinTech News
11.5 SpacePharma
  11.5.1 SpacePharma Company Details
  11.5.2 SpacePharma Microgravity Biopharmaceuticals Product Offered
  11.5.3 SpacePharma Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.5.4 SpacePharma Main Business Overview
  11.5.5 SpacePharma News
11.6 Varda Space Industries
  11.6.1 Varda Space Industries Company Details
  11.6.2 Varda Space Industries Microgravity Biopharmaceuticals Product Offered
  11.6.3 Varda Space Industries Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.6.4 Varda Space Industries Main Business Overview
  11.6.5 Varda Space Industries News
11.7 Voyager Technologies
  11.7.1 Voyager Technologies Company Details
  11.7.2 Voyager Technologies Microgravity Biopharmaceuticals Product Offered
  11.7.3 Voyager Technologies Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.7.4 Voyager Technologies Main Business Overview
  11.7.5 Voyager Technologies News
11.8 Sierra Space
  11.8.1 Sierra Space Company Details
  11.8.2 Sierra Space Microgravity Biopharmaceuticals Product Offered
  11.8.3 Sierra Space Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.8.4 Sierra Space Main Business Overview
  11.8.5 Sierra Space News
11.9 Space Phoenix Systems
  11.9.1 Space Phoenix Systems Company Details
  11.9.2 Space Phoenix Systems Microgravity Biopharmaceuticals Product Offered
  11.9.3 Space Phoenix Systems Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.9.4 Space Phoenix Systems Main Business Overview
  11.9.5 Space Phoenix Systems News
11.10 Rhodium Scientific
  11.10.1 Rhodium Scientific Company Details
  11.10.2 Rhodium Scientific Microgravity Biopharmaceuticals Product Offered
  11.10.3 Rhodium Scientific Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
  11.10.4 Rhodium Scientific Main Business Overview
  11.10.5 Rhodium Scientific News
11.11 Beijing Dawn Aerospace Bio-Tech
11.12 CASC

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Microgravity Biopharmaceuticals Market Size CAGR by Region (2026-2032) ($ millions)
Table 2. Major Players of Protein Crystal Growth
Table 3. Major Players of Microbial Fermentation
Table 4. Major Players of Advanced Disease Model Construction
Table 5. Major Players of Others
Table 6. Global Market Size by Type (2026-2032) ($ millions)
Table 7. Global Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 8. Major Players of Low Earth Orbit (160?2000 km)
Table 9. Major Players of Medium Earth Orbit (2,000?35,786 km)
Table 10. Major Players of Geostationary Orbit (35,786 km)
Table 11. Global Market Size by Orbital Altitude (2026-2032) ($ millions)
Table 12. Global Microgravity Biopharmaceuticals Market Size Market Share by Orbital Altitude (2026-2032)
Table 13. Major Players of 1?10 L
Table 14. Major Players of 10?100 L
Table 15. Major Players of Over 100 L
Table 16. Global Market Size by Bioreactor Capacity (2026-2032) ($ millions)
Table 17. Global Microgravity Biopharmaceuticals Market Size Market Share by Bioreactor Capacity (2026-2032)
Table 18. Global Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 19. Global Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 20. Date of Global Key Players Enter into Microgravity Biopharmaceuticals Market
Table 21. Global Key Players Microgravity Biopharmaceuticals Product Offered
Table 22. Key Players Microgravity Biopharmaceuticals Funding/Investment (Million USD)
Table 23. Funding/Investment by Regions
Table 24. Funding/Investment by End-Industry
Table 25. Key Players Microgravity Biopharmaceuticals Valuation & Market Capitalization (Million USD)
Table 26. Key Players Mergers & Acquisitions, Expansion Plans
Table 27. Microgravity Biopharmaceuticals New Product/Technology Launches
Table 28. Microgravity Biopharmaceuticals Industry Partnerships, Agreements, and Collaborations
Table 29. Microgravity Biopharmaceuticals Industry Mergers and Acquisitions
Table 30. Global Microgravity Biopharmaceuticals Market Size by Regions 2026-2032 ($ millions)
Table 31. Global Microgravity Biopharmaceuticals Market Size Market Share by Regions 2026-2032
Table 32. United States Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 33. United States Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 34. United States Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 35. United States Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 36. Europe Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 37. Europe Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 38. Europe Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 39. Europe Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 40. China Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 41. China Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 42. China Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 43. China Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 44. Rest of World Microgravity Biopharmaceuticals Market Size by Type (2026-2032) ($ millions)
Table 45. Rest of World Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Table 46. Rest of World Microgravity Biopharmaceuticals Market Size by Application (2026-2032) ($ millions)
Table 47. Rest of World Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Table 48. Key Market Drivers & Growth Opportunities of Microgravity Biopharmaceuticals
Table 49. Key Market Challenges & Risks of Microgravity Biopharmaceuticals
Table 50. Key Industry Trends of Microgravity Biopharmaceuticals
Table 51. Company A Company Details
Table 52. Companies Invested by Company A
Table 53. Company A Key Development and Market Layout
Table 54. Company B Company Details
Table 55. Companies Invested by Company B
Table 56. Company B Key Development and Market Layout
Table 57. Company C Company Details
Table 58. Companies Invested by Company C
Table 59. Company C Key Development and Market Layout
Table 60. BioOrbit Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. BioOrbit Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 62. Eascra Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Eascra Biotech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 64. Exobiosphere Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Exobiosphere Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 66. Space LiinTech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Space LiinTech Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 68. SpacePharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. SpacePharma Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 70. Varda Space Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Varda Space Industries Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 72. Voyager Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Voyager Technologies Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 74. Sierra Space Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Sierra Space Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 76. Space Phoenix Systems Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Space Phoenix Systems Microgravity Biopharmaceuticals Market Size (2025 VS 2031)
Table 78. Rhodium Scientific Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Rhodium Scientific Microgravity Biopharmaceuticals Market Size (2025 VS 2031)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Microgravity Biopharmaceuticals
Figure 2. Microgravity Biopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microgravity Biopharmaceuticals Market Size Growth Rate 2026-2032 ($ millions)
Figure 7. Microgravity Biopharmaceuticals Market Size by Region (2025 & 2032) ($ millions)
Figure 8. Global Microgravity Biopharmaceuticals Market Size Market Share by Type (2026-2032)
Figure 9. Global Protein Crystal Growth Market Size Growth Rate
Figure 10. Global Microbial Fermentation Market Size Growth Rate
Figure 11. Global Microgravity Biopharmaceuticals Market Size Market Share by Orbital Altitude (2026-2032)
Figure 12. Global Low Earth Orbit (160?2000 km) Market Size Growth Rate
Figure 13. Global Medium Earth Orbit (2,000?35,786 km) Market Size Growth Rate
Figure 14. Global Microgravity Biopharmaceuticals Market Size Market Share by Bioreactor Capacity (2026-2032)
Figure 15. Global 1?10 L Market Size Growth Rate
Figure 16. Global 10?100 L Market Size Growth Rate
Figure 17. Microgravity Biopharmaceuticals in New Drug Discovery
Figure 18. Global Microgravity Biopharmaceuticals Market: New Drug Discovery (2026-2032) ($ millions)
Figure 19. Microgravity Biopharmaceuticals in Preclinical Research and Translational Medicine
Figure 20. Global Microgravity Biopharmaceuticals Market: Preclinical Research and Translational Medicine (2026-2032) ($ millions)
Figure 21. Microgravity Biopharmaceuticals in Others
Figure 22. Global Microgravity Biopharmaceuticals Market: Others (2026-2032) ($ millions)
Figure 23. Global Microgravity Biopharmaceuticals Market Size Market Share by Application (2026-2032)
Figure 24. Global Microgravity Biopharmaceuticals Market Size in New Drug Discovery Growth Rate
Figure 25. Global Microgravity Biopharmaceuticals Market Size in Preclinical Research and Translational Medicine Growth Rate
Figure 26. Funding/Investment
Figure 27. Global Microgravity Biopharmaceuticals Market Size Market Share by Regions 2026-2032
Figure 28. United States Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 29. China Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 30. Europe Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 31. Rest of World Microgravity Biopharmaceuticals Market Size 2026-2032 ($ millions)
Figure 32. United States Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 33. United States Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030
Figure 34. Europe Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 35. Europe Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030
Figure 36. China Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 37. China Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030
Figure 38. Rest of World Microgravity Biopharmaceuticals Consumption Market Share by Type in 2030
Figure 39. Rest of World Microgravity Biopharmaceuticals Market Size Market Share by Application in 2030